Genus Capital Management Inc. Edwards Lifesciences Corp Put Options Transaction History

Genus Capital Management Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 29, 2024	SELL	$59.7 - $93.78 $5.81 Million - $9.13 Million	-97,359 Reduced 78.96%	25,940 $1.71 Billion
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $10.4 Million - $11.6 Million	123,299 New	123,299 $11.4 Billion
Q4 2023 Feb 06, 2024	BUY	$61.71 - $77.76 $4 Million - $5.05 Million	64,900 New	64,900 $4.95 Billion

1,350

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Genus Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Genus Capital Management Inc. with notifications on news.